🤝 𝐖𝐞𝐥𝐜𝐨𝐦𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐟𝐮𝐧𝐝, Fideliomed! ✍ Fideliomed is an innovative startup that specializes in a digital diagnostic platform designed for real-time diagnosis and targeted treatment of common and treatable diseases in primary care, with a particular emphasis on anemia. 💡 The concept of Fideliomed emerged in February 2022 from a team of professionals experienced in diagnostic innovation, including Simona Roggero, Francesco Chiara, and Marco Pasquandrea. Initially developed with the support of CV Lab - Cardiovascular Laboratory, the team has expanded to include a multidisciplinary group backed by various national and international partners in science, technology, and industry. Through effective collaboration, Fideliomed’s team has successfully turned their vision into a tangible 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐝𝐞𝐯𝐢𝐜𝐞 aimed at improving the quality of life for vulnerable individuals while simultaneously reducing healthcare costs. The prototype has already been validated, and a clear manufacturing process has been established to facilitate market access. 🤗 “Fideliomed 𝑖𝑠 𝑎𝑐𝑡𝑖𝑣𝑒𝑙𝑦 𝑠𝑒𝑒𝑘𝑖𝑛𝑔 𝑠𝑡𝑟𝑎𝑡𝑒𝑔𝑖𝑐 𝑝𝑎𝑟𝑡𝑛𝑒𝑟𝑠 𝑎𝑛𝑑 𝑖𝑛𝑣𝑒𝑠𝑡𝑜𝑟𝑠 𝑤ℎ𝑜 𝑠ℎ𝑎𝑟𝑒 𝑖𝑡𝑠 𝑣𝑖𝑠𝑖𝑜𝑛. 𝐼𝑛 𝑡ℎ𝑖𝑠 𝑐𝑜𝑛𝑡𝑒𝑥𝑡, 20Fund, 𝑎𝑙𝑜𝑛𝑔 𝑤𝑖𝑡ℎ 𝑆𝑒𝑟𝑟𝑎 ,𝑃𝑖𝑒𝑡𝑟𝑜, 𝐿𝑖𝑠𝑎, 𝑎𝑙𝑖𝑔𝑛𝑠 𝑝𝑒𝑟𝑓𝑒𝑐𝑡𝑙𝑦 𝑤𝑖𝑡ℎ Fideliomed’𝑠 𝑔𝑜𝑎𝑙𝑠 𝑏𝑦 𝑝𝑟𝑜𝑣𝑖𝑑𝑖𝑛𝑔 𝑠𝑢𝑝𝑝𝑜𝑟𝑡 𝑓𝑟𝑜𝑚 𝑎 𝑡𝑎𝑙𝑒𝑛𝑡𝑒𝑑 𝑡𝑒𝑎𝑚 𝑤𝑖𝑡ℎ 𝑠𝑖𝑔𝑛𝑖𝑓𝑖𝑐𝑎𝑛𝑡 𝑝𝑒𝑟𝑠𝑜𝑛𝑎𝑙𝑎𝑛𝑑 𝑒𝑛𝑡𝑟𝑒𝑝𝑟𝑒𝑛𝑒𝑢𝑟𝑖𝑎𝑙 𝑒𝑥𝑝𝑒𝑟𝑖𝑒𝑛𝑐𝑒, 𝑎𝑠 𝑤𝑒𝑙𝑙 𝑎𝑠 𝑎 𝑠𝑡𝑟𝑜𝑛𝑔 𝑐𝑜𝑚𝑚𝑖𝑡𝑚𝑒𝑛𝑡 𝑡𝑜 𝑖𝑚𝑝𝑎𝑐𝑡𝑓𝑢𝑙 𝑝𝑟𝑜𝑗𝑒𝑐𝑡𝑠 ”. Team: Simona Roggero, Francesco Chiara, Marco Pasquandrea, Silvia Montrucchio Lisa Tortolani Serra Elizabeth Falk Pietro Jonathan Bonanno Read more about our investments: https://lnkd.in/dcUU9Gr9 #20Fund #venturecapital #Fideliomed #digitaldiagnosticplatform #helpingdoctors #healpeople #startup #investment #investitor #founders #investinginwomen
20Fund
Mandanti di venture capital e private equity
Turin, Piedmont 863 follower
Backing Italian female founders with the capital, mentorship and relationships to grow their green businesses.
Chi siamo
20Fund invests in Italian female entrepreneurs who focus on their employees, support their communities and care for the planet. We are creating a lasting positive impact on women, culture and the environment.
- Settore
- Mandanti di venture capital e private equity
- Dimensioni dell’azienda
- 2-10 dipendenti
- Sede principale
- Turin, Piedmont
- Tipo
- Società privata non quotata
- Data di fondazione
- 2022
Località
-
Principale
Via della Rocca, 21
Turin, Piedmont 10123, IT
-
San Francisco , California 94133, US
Dipendenti presso 20Fund
-
Gabrielle Tenaglia
Head of Marketing at Lettuce | Consultant, Advisor, Fractional CMO │ Fierce advocate of women at work │ 2x Unicorn Scale-Ups | Ex-Omada Health…
-
Lisa Tortolani
Angel Investor | Co-Founder and Investor of 20Fund | Female Founded Sustainability Startups | Venture Capital For Italian Startups
Aggiornamenti
-
👏Congratulazioni Relicta - Innovation of Packaging
🥇 Con immenso orgoglio condivido che Relicta - Innovation of Packaging ha ricevuto il premio come Migliore Startup del #GlobalStartupProgram2024, organizzato da ITA - Italian Trade Agency e annunciato durante l’evento #SIOSWinter24 di StartupItalia Questo riconoscimento è una spinta a continuare il nostro lavoro con determinazione ed è il risultato del lavoro di squadra e della passione condivisa. Un ringraziamento a ITA - Italian Trade Agency per il supporto alle startup italiane e a StartupItalia per aver creato uno spazio unico di celebrazione dell’innovazione. Un grazie anche a WeRoad per aver reso questo momento ancora più speciale mettendo a disposizione un voucher di viaggio che ci permetterà di organizzare un ritiro aziendale indimenticabile. Infine, voglio ringraziare tutte le persone straordinarie che ho avuto il piacere di incontrare durante #SIOSWinter24. Ogni conversazione, incontro e scambio di idee è stato un arricchimento personale e professionale. 🚀 Il viaggio continua, e il meglio deve ancora venire! #Relicta #GlobalStartupProgram2024 #MiglioreStartup #SIOSWinter24 #Innovation #Gratitude #Sustainability #WeRoad #StartupItalia #Inspiration
-
#ImpactConnections 👥 We are working to create a network of connections between "Impact" funds in both Italy and Europe. 👉 We met Omar Fulvio Bertoni - Entrepreneur, Business Angel, Board Member, Impact Investing. 🤗 “Omar thank you for the time dedicated to our call. It was so refreshing to learn about your concerns and goals for the #Italian #impact investment ecosystem. You are an example to all of us. We would need a couple more of you to make Italy fulfill it’s full potential. I look forward to working with you. “
-
💡Cosa è successo a Bi-rex in seguito all’investimento di 20Fund ? 🍃#Startup #MeasuringImpact con il racconto di Bi-rex a più di un anno dall’investimento. 🤗Grazie Bi-rex per i risultati raggiunti, il vostro impatto contribuirà a creare un futuro sostenibile! Bi-rex Greta Colombo Dugoni Monica Ferro Pietro Jonathan Bonanno Serra Elizabeth Falk Lisa Tortolani #Birex #MeasuringImpact #20Fund #webelieveinyou #ourvision #invest #investing #investinginwomen #investinginsustainability #investinginitaly #finance #venturecapital #vc #women #womenivc #womeninvestors #womeninventors #womensupportingwomen #womensupportingwomeninbusiness #sustainability #womenfounders #womenandenvironment #socialimpactinvesting
-
Sarà presente anche Fideliomed , startup che è entrata a far parte del portfolio di 20Fund
One week away! Join us on Thursday, December 12th at Tri-C Corporate College East to hear nine Trailblazer HealthTech Accelerator startups pitch their groundbreaking solutions. This is your chance to engage with visionary founders as they prepare for their next funding milestones. After the pitches, stay for a networking happy hour to connect with the startups and the broader tech community. 🔗Reserve your spot here: https://ow.ly/GQYC50Ub3a0 Word of Mouth + smallTalk + Auxilium Health, Inc + Fideliomed + Coologics + HealthQ.Ai + Beenabled + GrAI Med + Elios #HealthTech #Investors #StartupShowcase #Innovation
-
👏Finalista del Barracuda Bowl 2024 è la startup Fideliomed : piattaforma diagnostica che analizza i biomarcatori per rilevare precocemente l' anemia e altre condizioni. Nei prossimi giorni racconteremo la storia di Fideliomed che è entrata a far parte del portfolio di 20Fund ...intanto tifiamo per loro! 💪 #staytuned UMassM2D2
We're thrilled to announce our 2024 Barracuda Bowl Finalists! These startups will pitch their point-of-care and proactive health innovations on December 11th at Mintz in Boston. Here is the lineup: 🦈 Advanced Silicon Group: Silicon nanowire sensors for low-cost, rapid protein detection in proactive health and at-home diagnostics. 🦈 University of Massachusetts Lowell Fabric Discovery Center: Fabric-based dry electrodes for continuous, adhesive-free EKG monitoring. 🦈 Wellinks: Predictive AI and physiological monitoring to detect early deterioration in cardiopulmonary patients. 🦈 GattaCo Inc. : Point-of-care tech enabling patients to draw, process, and send blood samples independently. 🦈 Fideliomed: Diagnostic platform analyzing biomarkers to detect anemia and other conditions early. 🦈 Lagomics: Streamlined antibody discovery targeting multiple antigens to reduce off-target effects. 🦈 Echopoint Medical Ltd: Fiber optic sensors offering real-time, minimally invasive coronary artery assessments. Join us for an exciting evening as these up and coming startups present their solutions to a panel of reviewers in a "Shark Tank" style format, who will provide valuable feedback to help shape the future of healthcare innovation. Plus, you'll also have the chance to meet representatives from Advanced Research Projects Agency for Health (ARPA-H), the federal agency driving transformative health R&D, and learn about incredible opportunities in this space. Join us from 3-7:30 PM: https://lnkd.in/e9DnKb4e
-
20Fund ha diffuso questo post
Oggi accendiamo i riflettori sui traguardi di Relicta - Innovation of Packaging, una delle start-up innovative nel portfolio di Scientifica Venture Capital! Relicta, che ha sviluppato una bioplastica idrosolubile, biodegradabile e compostabile ottenuta dagli scarti di lavorazione dell’industria ittica, ha chiuso un nuovo round di investimento con 20Fund La start-up si distingue non solo per il potenziale innovativo della sua tecnologia ma anche per la forza del suo team in cui alcuni dei ruoli strategici sono affidati a Andrea Farina e Mariangela Melino, donne di grande talento e visione. Il successo di Relicta conferma la capacità di Scientifica Venture Capital di selezionare ed investire su start-up altamente attrattive per il mercato. Inoltre, conferma l’importanza di sostenere realtà che valorizzano il contributo attivo delle donne nell'innovazione tecnologica e scientifica. Stay tuned per scoprire i passi avanti delle nostre start-up!
-
🤝 Welcome to our Fund, 𝗥𝗲𝗹𝗶𝗰𝘁𝗮! ✍ 𝗥𝗲𝗹𝗶𝗰𝘁𝗮 is an innovative startup founded in February 2020 that has developed a water-soluble, biodegradable, compostable, and transparent biofilm made by the fish industry by-products. It's an idea that combines sustainability and innovation, turning waste into valuable resources. 💡 The idea was born from Davide Sanna, Ph.D.‘s doctoral project and his encounter with Andrea Farina, Mariangela Melino, Giovanni Conti, and Matteo Sanna. The 𝗥𝗲𝗹𝗶𝗰𝘁𝗮 team was formed and consolidated within the CLab at the University of Sassari. The turning point for the team came when Davide presented his invention and highlighted a unique characteristic: “𝘐 𝘪𝘯𝘷𝘦𝘯𝘵𝘦𝘥 𝘢 𝘣𝘪𝘰𝘱𝘭𝘢𝘴𝘵𝘪𝘤 𝘮𝘢𝘵𝘦𝘳𝘪𝘢𝘭 𝘵𝘩𝘢𝘵 𝘩𝘢𝘴 𝘢 𝘱𝘳𝘰𝘣𝘭𝘦𝘮: 𝘪𝘵 𝘥𝘪𝘴𝘴𝘰𝘭𝘷𝘦𝘴 𝘶𝘱𝘰𝘯 𝘤𝘰𝘯𝘵𝘢𝘤𝘵 𝘸𝘪𝘵𝘩 𝘸𝘢𝘵𝘦𝘳”. The team recognized this feature as a groundbreaking opportunity. 🔬 Between 2023 and 2024, thanks to funding from the venture capital firms Scientifica Venture Capital and Vertis SGR, the Terranext acceleration program (CDP), and public funding through the Startup Voucher program promoted by Sardegna Ricerche, the industrialization plan began. These activities have allowed 𝗥𝗲𝗹𝗶𝗰𝘁𝗮 to reach a technology readiness level (TRL) of 7. Alongside technological validation, commercial validation is also underway, as 𝗥𝗲𝗹𝗶𝗰𝘁𝗮 is currently collaborating with several companies interested in using its material for their packaging solutions. 🙏 "Thanks to the support of 20Fund, it will now be possible to finalize the industrial Proof of Concepts. The 𝗥𝗲𝗹𝗶𝗰𝘁𝗮 team first met 20Fund during the Terranext Demo Day, where a shared vision of sustainability, innovation, and technology transfer emerged. This connection was further strengthened through ongoing discussions with Scientifica Venture Capital. We are thrilled to welcome the 20Fund team into our growing family! " Relicta - Innovation of Packaging Read more about our investments: https://lnkd.in/dcUU9Gr9 #20Fund #venturecapital #Relicta #Innovationofpackaging #startup #investment #investitor #founders #investinginwomen #investinginsustainability #investinginitaly
-
🤗Buon Lunedì! 🤗 "Abbiamo premiato Boniviri perché abbiamo riconosciuto la qualità dei prodotti che scelgono e il benessere sostenibile che portano alla società e all' ambiente " Riccardo Illy ha così motivato il premio "Polo del Gusto" consegnato a Boniviri | Certified B Corporation™ Nell' articolo di Andrea Bonafede sul Corriere della Sera si parla degli obiettivi di Boniviri | Certified B Corporation™
-
Oggi Pietro Jonathan Bonanno, co-founder di 20Fund ha avuto l'opportunità di intervenire alla nona lezione della 𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐀𝐜𝐚𝐝𝐞𝐦𝐲 di Italian Tech Alliance. La lezione aveva come titolo: 𝐄𝐒𝐆: 𝐀𝐋𝐋𝐀 𝐅𝐑𝐎𝐍𝐓𝐈𝐄𝐑𝐀 𝐃𝐄𝐋𝐋' 𝐈𝐍𝐍𝐎𝐕𝐀𝐙𝐈𝐎𝐍𝐄 con un focus su come i criteri ESG vengono applicati nella selezione delle startup. Pietro Jonathan Bonanno ha condiviso la sua esperienza insieme ai colleghi Federico Giannetti, PhD di COREangels, Simona Testoni di a|impact - Avanzi Etica SICAF EuVECA S.p.A. dopo una lezione frontale tenuta da Omar Fulvio Bertoni di LifeGate Way. La 𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐀𝐜𝐚𝐝𝐞𝐦𝐲 è un percorso di formazione sul funzionamento del #VentureCapital e dell' innovazione. Ha come obiettivo formare i futuri professionisti del settore coniugando il rigore dell' insegnamento con l' esperienza di chi opera da anni in questo ambito. #20Fund #VentureAcademy #VentureCapital #VC